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The ﬁrst step of HIV-1 infection involves interaction between the v i r a lg l y c o p r o t e i ng p 1 2 0a n dt h eh u m a nc e l l u l a rr e c e p t o rC D 4 .
Inhibition of the gp120-CD4 interaction represents an attractive strategy to block HIV-1 infection. In an attempt to explore the
known lack of aﬃnity of murine CD4 to gp120, we have investigated peptides presenting the putative gp120-binding site of
murine CD4 (mCD4). Molecular modeling indicates that mCD4 protein cannot bind gp120 due to steric clashes, while the larger
conformationalﬂexibilityofmCD4peptidesallowsaninteraction.Thisﬁndingisconﬁrmedbyexperimentalbindingassays,which
alsoevidencedspeciﬁcityofthepeptide-gp120interaction.MoleculardynamicssimulationsindicatethatthemCD4-peptidestably
interacts with gp120 via an intermolecular β-sheet, while an important salt-bridge formed by a C-terminal lysine is lost. Fixation
oftheC-terminusbyintroducingadisulﬁdebridgebetweentheN-andC-terminiofthepeptidesigniﬁcantlyenhancedtheaﬃnity
to gp120.
1.Introduction
AIDS is one of the most dramatic infection diseases in
humans, not only in developing countries but also in the
western world. The disease is caused by HIV-1, which infects
CD4+ cells, that is, T helper cells and macrophages. The ﬁrst
step in cell invasion is binding of the HIV-1 envelope protein
gp120 to the cellular surface receptor CD4 [1]. Attachment
inhibitors are a class of anti-HIV-1 drugs that interfere with
this very ﬁrst step of viral entry and include derivatives of
natural ligands, antibodies, and small synthetic compounds
[2].
The structural details of the gp120-CD4 interaction
are known from several complex crystal structures [3–7],
thus providing the basis for a rational design of inhibitors.
The T cell receptor CD4 belongs to the immunoglobulin
superfamilyandconsistsofashortcytoplasmatictail,asingle
transmembrane helix, and four tandem immunoglobulin
repeats (D1–D4) [8]. Residues 25–64 of domain D1 consti-
tute the binding site for gp120 [4]( Figure 1(a)). The gp120-
binding site is composed of a triple-stranded antiparallel
β-sheet (strands C, C ,a n dC   ) followed by strand D that
exhibitsaratherpoorβ-strandgeometry .Intotal,22residues
of CD4 contact 26 amino acids of gp120 [4]. Strand C  
of CD4 establishes hydrogen bonds to strand β15 of the
gp120 CD4-binding loop. This leads to the extension of
the three stranded core β-sheet of CD4 (C-C -C  )b yo n e
strand of gp120, establishing an intermolecular β-sheet at
the interface. Key residues in human CD4 for its interaction
with gp120 are F43 and R59, located in strand C   and
D, respectively (Figure 1(b)). F43 binds into a hydrophobic
cavity of the gp120 surface, and R59 forms a salt-bridge with
D368 of gp120 [4]. The signiﬁcance of F43 and R59 for
gp120 recognition is supported by mutational data revealing
that mutation of F43 [9–11]o rR 5 9[ 11, 12] to alanine or
glycine reduces gp120-binding. One of the most devastating2 Advances in Bioinformatics
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Figure 1: Sequence comparison and interactions of CD4. (a) Sequence alignment of human and murine CD4 in the region of the
immunglobulin-like domain 1 (D1). Nonconserved and conserved residues are shown in black and gray, respectively. The stretch covered by
the mCD4-M (residues 22 to 66) peptide is highlighted in green. The position of β-strands is indicated as arrows above the sequence. This
alignment represents the ﬁnal sequence alignment used for homology modeling. Information about alternative alignments and the quality
of the resulting models is given in Supplementary Material available online at doi:10.1155/2011/736593. (b) Region of interaction between
CD4 and gp120. gp120 is shown in light gray; the diﬀerent structural parts of CD4 are color coded as follows. The triple-stranded β-sheet
of the CD4 domain D1 (termed “core”) is shown in yellow and green. The green color highlights strand C   that forms an intermolecular
β-sheet with strand β15 of gp120. Loops connecting the β-strands of the core are shown in red, and the C-terminally adjacent strand D is
colored in blue.
mutations, F43A, leads to a 500-fold reduction of gp120-
binding [11].
This detailed structural and functional knowledge has
been exploited in the past to derive peptides from human
CD4 (hCD4) that bind to gp120, thereby inhibiting the
gp120-CD4 interaction [13–15]. In this context, CD4 mim-
ics, in which key residues for the interaction with gp120 were
grafted on the scorpion toxin scyllatoxin, represent a very
potent group of compounds [13].
Apart from their biomedical signiﬁcance as inhibitors
of protein-protein interactions, synthetic mimics of protein
binding sites are also valuable tools for the exploration of
these interactions at the molecular level. The molecular basis
of the fact that mice cannot be infected with HIV [16]
lies in the lack of aﬃnity of HIV gp120 to murine CD4
(mCD4)[17–19],in spite ofa fairlyhighsequencehomology
(55%identity)betweentheﬁrstextracellulardomain(D1)of
murine and human CD4, which contains the binding site for
gp120.
Therefore, the ﬁrst goal of our work was to understand
the structural origin for this lack of aﬃnity of gp120 to
mCD4. In a second step, we could show by a combination of
computational predictions and binding assays that an mCD4
mimetic peptide comprising residues 22–66 can bind gp120.
The mode of this peptide-gp120 interaction has also been
studied in greater detail by molecular dynamics simulations,
with the aim to propose, generate, and evaluate modiﬁed
mCD4 mimetic peptides with improved aﬃnity to gp120.
2.MaterialandMethods
2.1. Peptide Synthesis and Binding Experiments. Peptide syn-
thesis and binding assays were done essentially as described
earlier [20]. Brieﬂy, peptides (refer to Table 2 for sequences)
were synthesized as C-terminal amides by Fmoc/t-Bu-based
solid-phase synthesis using an automated multiple pep-
tide synthesizer and N-terminally acetylated. Cleaved pep-
tides were puriﬁed by preparative HPLC. A cysteine residue
was added to the linear peptides, enabling covalent attach-
ment to SH binding plates in the binding assay. The
C23–C65 disulﬁde bridge in mCD4-M∗∗ was formed byAdvances in Bioinformatics 3
a i ro x i d a t i o n .T h i sp e p t i d e ,a sw e l la sas e c o n dc o p yo f
hCD4-M, was equipped with a His6-tag, enabling attach-
ment of the peptides to Ni-NTA assay plates. Binding
assays were performed in SH-binding or Ni-NTA microtiter
plates, respectively, to which the peptides were coated at
1μM. Binding of gp120 (0.5μg/mL) to the peptides was
detected using a primary anti-gp120 antibody, followed by a
peroxidase-labeledsecondaryantibodyinconjunctionwitha
chromogenic substrate, enabling a quantitative colorimetric
readout. Relative aﬃnities were calculated by dividing the
absorbances obtained for each peptide by the absorbance
obtained for hCD4-M, which enabled comparison of results
from diﬀerent assays using diﬀerent chemistries for peptide
attachment to the plates.
2.2. Homology Modeling of Murine CD4. Am o d e lo fm C D 4
consistingofdomainsD1andD2wasgeneratedbasedonthe
crystalstructureof human D1/D2–CD4 thatwas determined
in complex with gp120 (1RZJ [3]). The murine and human
D1/D2–CD4proteinsexhibitasequenceidentityof52%thus
allowing the application of homology modeling techniques.
Since two slightly diﬀerent alignments of human and murine
C D 4h a v eb e e nr e p o r t e di nt h el i t e r a t u r e( F i g u r eS 1 ) ,t w o
diﬀerentmodelsofmCD4wereconstructed.Foreachmodel,
the sequence of mCD4 was aligned to hCD4 protein using
the SwissPDB viewer v3.7 [21] and the mCD4 structure
was generated with SwissModel [22–24]. Model quality was
assessed based on the QMEAN score [25, 26]p r o v i d e db y
Swiss-Model and on further veriﬁcation with PSQS [27, 28]
and ProSA [29, 30]. Fitting of the mCD4 structure onto
the hCD4 coordinates in the hCD4-gp120 complex yielded
a model of a putative mCD4-gp120 complex. This complex
was analyzed for clashes using WHAT CHECK [31].
2.3. Molecular Dynamics Simulations of the gp120-mCD4(22–
66) Complex. The gp120-binding properties of a peptide
corresponding to residues 22–66 of mCD4 were investigated
by a 100-ns molecular dynamics (MD) simulation. This
simulationwasbasedonthemodeledmCD4-gp120complex
structure from which all mCD4 residues outside the 22–
66 stretch were deleted. N- and C-termini of the mCD4
(22–66) peptide were blocked with acetyl and N-methyl
amidegroups,respectively.Theprotonationstateofhistidine
residues was checked visually and if necessary either Nδ
or Nε protonation was chosen to ensure optimal hydrogen
bonding. MD simulation was performed by the AMBER10
[32]a n dA M B E R 1 1[ 33] suite of programs together with the
force ﬁeld ﬀ99SB [34] including updated torsion potentials.
Using the AMBER11 tool tleap [33], the system was neu-
tralized with Cl− i o n sa n dp l a c e di naT I P 3 P[ 35]w a t e rb o x
with at least 12 ˚ A space to the box boundaries. Subsequently,
the system was minimized, heated, and pressure equilibrated
according to a previous simulation protocol [36]. Mini-
mization was performed in three steps. Initially, only solute
molecules were minimized while restraining protein atoms
with a force constant of 500kcalmol−1 ˚ A−2. Next, side chains
were relaxed while forcing the backbone to its initial position
by applying the same force constant. Finally, all constraints
were removed allowing the whole system to relax. Each step
involved250stepsofsteepestdescentfollowedby250stepsof
conjugate gradient minimization. The minimized structure
was subjected to MD simulation at 310K using a time step
of 2 fs and periodic boundary conditions. SHAKE [37]w a s
applied to ﬁx all hydrogen involving bonds. After heating
the system from 10 to 310K (100ps, NVT ensemble), and
equilibrating it at constant pressure (400ps, NPT ensemble
at 1bar), it was subjected to a 100-ns production phase
carried out with Amber10 [32]. The obtained trajectory was
processed utilizing the AMBER11 tool ptraj. Structure vis-
ualization was performed with VMD [38].
3. Results and Discussion
3.1. Structural Basis for the Lack of gp120-Binding by Murine
CD4. Previous experiments have revealed that the mCD4
proteindoesnotinteractwithHIV-1gp120[16–18].Toiden-
tify the structural properties responsible for this lack of
interaction, a homology model of the mCD4-gp120 complex
was generated.
Homology modeling of mCD4 is hampered by the fact
that slightly diﬀerent sequence alignments between hCD4
and mCD4 have been reported in the past [39–41], which
diﬀer in the alignment of the C   D-loop (Figure S1). To
identify the alignment, which is more suitable for compar-
ative modeling, two structures were generated based on the
diﬀerent sequence alignments and compared with respect to
their model quality (Table S1, Figures S2, and S3). Inter-
estingly, both models exhibit clashes at the mCD4-gp120
interface, which can, therefore, be considered as an intrinsic
featureimpeding interaction of the complex regardlessof the
CD4 sequence alignment used. Therefore, all further analysis
is based on the murine model 1, which exhibits the more
f a v o r a b l es t r u c t u r a lp r o p e r t i e s( T a b l eS 1 ) .
The overlay between the murine and human CD4-gp120
complexes reveals the high overall structural similarity (Fig-
ure 2(a)), while a detailed inspection of the interface high-
lights several clashes present in the mCD4-gp120 complex
(Figure 2(b)). Clashing residues are predominantly located
in the loops ﬂanking β-strand C   (C C  -loop, C  -D-loop),
two regions that show sequence insertions in mouse com-
paredtohumanCD4(Figure 1).Structuralanalysisidentiﬁes
several residues that form clashes >0.8 ˚ A( Table 1). The
largest intermolecular clash is found between G49, located in
the C  D-loop, and S365, located in the CD4-binding loop of
gp120, with a size of 1.95 ˚ A. An attempt to remove this clash
by a 500-ps MD simulation in explicit solvent resulted in a
very unfavorable backbone geometry of G49: ϕ = +159.0◦
and ψ = −86.6◦ (compared to ϕ = −81.2◦, ψ = +27.2◦ in
the initial model). Furthermore, K42 and V44 contribute
signiﬁcant clashes to the interface. K42, an insertion in
the C C  -loop, clashes with two residues of the bridging
sheet of gp120. The larger of the clashes is formed between
the K42 (mCD4) and K429 (gp120) side chains (Table 1,
Figure 2) indicating that electrostatic repulsion additionally
counteracts the mCD4-gp120 complex formation.
Valine44, the sequential equivalent to F43 in hCD4,
overlaps with I371. Interestingly, the described clashes aﬀect4 Advances in Bioinformatics
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Figure 2: Clashes of murine CD4 with gp120. (a) Overlay of the unbound mCD4 model onto the hCD4-gp120 complex structure 1RZJ [3].
(b) Close-up of the clash area. Clashes are predominantly found for residues in the loops ﬂanking β-strand C   (G48, G49, K42) and for V44.
The respective loops are longer in mouse compared to human CD4 (cf. alignment Figure 1(a)). Strand C   is labeled. hCD4, mCD4, and
gp120 are colored white, blue, and pink, respectively. Clashing residues of mCD4 and gp120 are shown in blue and pink spaceﬁll.
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Figure 3: Binding aﬃnities of CD4 peptides. Relative aﬃnities (hCD4-M = 1) to HIV-1 gp120 of peptides mimicking the putative gp120-
binding site of human (hCD4-M) and murine CD4 (mCD4-M), as well as peptide variants in which the hot spot residues were replaced by
alanine (hCD4-M∗ and mCD4-M∗, resp.), and a cyclized mCD4 mimetic peptide (mCD4-M∗∗,s e eTable 2 for peptide sequences).
Table 1: Clashes of mCD4with gp120. WHAT CHECK analysis of clashes detected between mCD4 with gp120. Allclashes> 0.8 ˚ Aa r el i s t ed ;
bb and sc denote clashes by backbone or side-chain atoms. The clashes are visualized in Figure 2.
gp120 mCD4 Clash size [˚ A]
Region Residue-ID Residue-ID Region
CD4-binding loop S365 (sc) G49 (bb) C  D-loop insertion 1.95
β20/β21 (bridging sheet) K429 (sc) K42 (sc) C C  -loop insertion 1.64
β20/β21 (bridging sheet) Q428 (bb) K42 (sc) C C  -loop insertion 1.27
CD4-binding loop I371 (sc) V44 (sc) C   (F43/V44) 0.87
CD4-binding loop S365 (sc) G48 (bb) C   0.84Advances in Bioinformatics 5
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Figure 4: Intrinsic stability and gp120-interaction of the mCD4 peptide core. (a) Scheme of intra- and intermolecular hydrogen bonds
and analyzed distances and torsion angles. Measured distances are marked d1–d7. Residues selected for torsion analysis are highlighted.
(b) Dihedral angles of residues V44 to R47 are shown as a function of time. ϕ angle (Ci−1-Ni-Ci
α-Ci)i nb l a c k ,ψ angle (Ni-Ci
α-Ci-
Ni+1) in gray. Distances were measured between main chain hydrogen donor and acceptor atoms. (c) Zoom into the interface and
comparison of the two interfaces mCD4-peptide-gp120 and hCD4-gp120 (1RZJ). Overlay of a representative snapshot after 90ns onto
crystal structure of the gp120-hCD4 complex. Fit on residues 362–369 of β1 5 .m C D 4 - p e p t i d ea n dh C D 4 - p r o t e i na r ec o l o r e di ng r e e na n d
gray, respectively. (d) Hydrogen bond distances between β-strands C/C  and C /C   and intermolecular hydrogen bond distances between
C   and β15.
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Figure 5: Van der Waals packing of V44 at the peptide-gp120 interface. (a) Enlargement of the interface. V44 of β-strand C   packs tightly
into a pocket of the gp120 surface. (b) Replacement by alanine leads to loss of van der Waals packing. (c) Interaction energy of V44 with
gp120. Total energy, electrostatic and van der Waals contribution are colored in black, gray, and blue, respectively.
residues and positions where human and mouse sequences
diverge. Those ﬁndings are in line with previous studies that
demonstrated a complete loss of binding aﬃnity following
K- and GS-insertion in C  -ﬂanking loops of hCD4 [39].
In conclusion, clashes of the loops ﬂanking strand C  , that
are longer in mCD4, are most likely the major reason for
impeded gp120-binding of mCD4.
The fact that gp120 mainly forms clashes with the longer
loops of mCD4 prompted us to investigate whether these
clashes might be removed in an mCD4 mimetic peptideAdvances in Bioinformatics 7
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Figure 6: Fluctuations of torsion angles in loops ﬂanking strand C   of mCD4-M. (a) Schematic presentation of the mCD4-M peptide
topology. Analyzed loops are colored red. (b) Dihedral angles of the loops ﬂanking strand C   as function of simulation time are shown in
the left and right column, respectively. ϕ angle (Ci−1-Ni-Ci
α-Ci)a n dψ angle (Ni-Ci
α-Ci-Ni+1) are colored in black and gray, respectively.
Table 2: Sequences of CD4 mimetic peptides. hCD4-M and mCD4-M represent the wild-type mimetic peptides presenting residues 22–64
of hCD4 and 22–66 of mCD4, respectively. Residues of hCD4-M and mCD4-M that were replaced by alanine in hCD4-M∗ and mCD4-M∗,
respectively, are shown in bold. mCD4-M∗∗ represents a cyclic peptide that was proposed based on the computational simulations. The
position of the engineered disulﬁde bond is indicated by brackets next to the involved cysteine residues.
Peptide Sequence
hCD4-M Ac-C-Ahx∗-22KSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQ64-NH2
Ac-HHHHHH-Ahx-KSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQ-NH2
hCD4-M∗ Ac-C-Ahx-KSIQFHWKNSNQIKILGNQGSALTKGPSKLNDRADSAASLWDQ-NH2
mCD4-M Ac-C-Ahx-22KITVFTWKFSDQRKILGQHGKGVLIRGGSPSQFDRFDSKKGAWEK66-NH2
mCD4-M∗ Ac-C-Ahx-KITVFTWKFSDQRKILGQHGKGALIRGGSPSQFDRFDSAAGAWEK-NH2
mCD4-M∗∗ Ac-HHHHHH-Ahx-K [CTVFTWKFSDQRKILGQHGKGVLIRGGSPSQFDRFDSKKGAWC]K- NH2
∗Ahx: ε-aminohexanoic acid (spacer between tag and peptide sequence).
(mCD4-M) due to its larger conformational freedom. Inter-
estingly,energyminimizationissuﬃcienttoremoveallinter-
molecular clashes (>0.4 ˚ A) between such a peptide and
gp120.Inordertoensurethatthisﬁndingisnotanartifactof
the applied force ﬁeld, the respective peptide was synthesized
and its gp120-binding aﬃnity was veriﬁed experimentally.
3.2. Experimental Investigation of the gp120-Binding of
CD4-Derived Peptides. Peptides comprising residues 22–
66 of mCD4 (termed mCD4-M) and 22–64 of hCD4
(termed hCD4-M), respectively, were synthesized and their
gp120-bindingaﬃnitiesexperimentallydetermined(Table 2;
Figure 3). This experiment shows that mCD4-M is indeed8 Advances in Bioinformatics
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Figure 7: Contacts of K60 and K61 of mCD4-M at the gp120 interface. (a) Interaction energy of K60 and K61 during the simulation.
Total energy, electrostatic, and van der Waals contibution are colored in black, blue, and red respectively. (b) Visualization of inter-
and intramolecular contacts transiently established by K60 and K61 during simulation. Snapshots were selected at time points when the
intermolecular interaction of K60 or K61 was maximal. Peptide and gp120 are colored in green and purple, respectively. Arrows indicate
detachment of strand D.
capable of binding to gp120, and that this interaction is only
slightly weaker than that of the homologous hCD4-M pep-
tide.
To verify that the binding of the peptides is speciﬁc, var-
iants (hCD4-M∗,m C D 4 - M ∗; Table 2) were generated that
address the hot spot residues crucial for gp120-binding
known from the gp120-CD4 crystal structures [3–7]. In
hCD4-M, F43 and R59 were replaced by alanine. Due to
sequence diversity, the corresponding residues in mCD4-M
are V44 and K61 (Figure 1(a)). In these peptides, also R58
(K60 in the murine peptide) was replaced by alanine to
avoid functional compensation of R59 (K61 in the murine
peptide) by the sequentially adjacent basic residue, which
might occur in peptides due to a higher ﬂexibility compared
to proteins. Binding of either triple variant to gp120 was
notablyreduced,indicatingthatmCD4-Mspeciﬁcallytargets
the CD4-binding site of gp120 (Figure 3). This suggests that
the lack of interaction detected for mCD4 protein is not
due to the sequence of mCD4 itself, but most likely to the
rigid conformation imposed by the immunoglobulin fold.
Therefore, the aﬃnity can at least partially be restored in the
more ﬂexible mCD4 peptides.
3.3. Structural Analysis of the mCD4-M-gp120 Interaction.
To understand the binding of mCD4-M in greater detail, a
100-ns molecular dynamics simulation was performed for
the peptide-gp120 complex. Subsequently, the diﬀerent key
interaction regions were analyzed in greater detail.Advances in Bioinformatics 9
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Figure 8: Optimization of mCD4-M. (a) mCD4-peptide-gp120 complex at the beginning (left) and after 100-ns MD simulation (right).
For color-coding refer to Figure 4. (b) Visualization of engineered disulﬁde bond C65–C23 yielding a cyclic peptide with enhanced gp120-
binding aﬃnity.
The peptide core contains three β- s t r a n d s ,C ,C  ,a n d
C  , assembled in an antiparallel fashion. Stand C   directly
interacts with strand β15 of gp120 (Figure 1(b), Figure 4(a)).
Hence, those interactions were analyzed over the course of
simulation. For the intramolecular C-C -C  β-sheet, hydro-
gen bond distances and torsion angles were monitored over
time and are plotted in Figures 4(b) and 4(d). Distances
between main chain nitrogen and oxygen atoms range
between 2.5–3.0 ˚ A and are almost preserved during simula-
tionindicatingstabilityofcorehydrogenbonding(seed1–d4
in Figure 4(d)). Analysis of torsion angles ϕ (Ci−1-Ni-Ci
α-Ci)
and ψ (Ni-Ci
α-Ci-Ni+1)r e v e a l e da ni d e a lβ-sheet backbone
geometry for residues V44 to R47 of strand C   with mean
ϕ and ψ values ranging at negative and positive values
characteristic for a β-sheet. Taken together, preservation
of hydrogen bond distances and β-sheet backbone angles
over time guarantees the stability of the peptide core. This
intrinsic stability also is the prerequisite for the correct
positioning of the peptide at the gp120-interface. Here, the
peptide forms three backbone hydrogen bonds to β15 of
the CD4-binding loop of gp120 during simulation time
(see d5–d7 in Figure 4(d)). Hydrogen bonds are established
between residues L45 and R47 of CD4 and D368 and G366
of gp120. One of the contacts (R47(O)-G366(N)) exhibits
larger ﬂuctuations; however, a transient hydrogen bonding
can be detected over the entire simulation time (distance d7
in Figure 4(d)). The three hydrogen bonds are arranged in
an antiparallel β-sheet fashion, thereby extending the C-C -
C  -central β-sheet by strand β15 across the interface. When
comparing the peptide interface to the human CD4-gp120
complex of the crystal structure, a striking similarity can
be noted both with respect to the β-sheet structure and the
hydrogen bonding pattern (Figure 4(c)). The weaker third
hydrogen bond detected in the mCD4-M-gp120 interface
also exhibits a nonoptimal geometry in the hCD4-gp120
interface thus supporting our results [4, 42].
In addition to the intermolecular β-sheet structure, the
interface is stabilized by tight van der Waals packing of V44
into a cavity of gp120 as shown in Figure 5. Tight packing
is also reﬂected in the good interaction energy of V44 which
is dominated by a strong van der Waals term (Figure 5(c)).
In contrast to the mCD4 protein, where V44 causes interface10 Advances in Bioinformatics
clashes (Figure 2 and Table 1), the conformational plasticity
of the peptide allows the residue to penetrate into the cavity.
This interaction is structurally reminiscent to that of F43
in human CD4, which extends deeply into the F43-cavity
of gp120 [4], forming a key contact of the hCD4-gp120
interface. An F43A mutation in human CD4 leads to a dra-
matic reduction (500-fold) of gp120-binding [11].
Thisdataisalsoinagreementwithourexperimentaldata
for the peptides showing that replacement of F43, R58, and
R59 (hCD4-M∗), as well as V44, K60, and K61 (mCD4-M∗)
with alanine clearly diminished binding to gp120 (Figure 3).
The methyl side chain of alanine cannot compensate for
the missing van der Waals packing of the longer hydropho-
bic valine side chain, resulting in a hole in the pocket
(Figure 5(b)). In conclusion, the stability of the peptide core
allows the formation of an intermolecular β-sheet structure
and a tight van der Waals packing at the gp120 interface.
The next analysis focused on the loops ﬂanking strand
C   in mCD4-M. These loops, which are longer in mCD4
(Figure 1), reside at the gp120 interface and form clashes
in the complex of full-length mCD4 (Figure 2). In order to
investigate the conformation of these peptide loops upon
gp120-binding, the torsion angles of the respective residues
were monitored over simulation time. Contrary to the con-
formationally stable strand C  , the ﬂanking loops exhibit
much greater ﬂuctuation of their backbone geometry over
time (Figure 6). A pronounced ﬂexibility of backbone dihe-
dral angles is detected for residues G41 and K42, located
in the C C  -loop, and residues G48 and G49, residing in
the C  D-loop. The higher loop ﬂexibility also oﬀers an ex-
planation for the absence of clashes in mCD4-M, which
are observed for the mCD4 protein (Figure 2). In addition,
the conformational ﬂexibility of K42 allows to remove the
electrostatic repulsion that is observed between K42 and
K429 of gp120 in the complex with the mCD4 protein.
An enhanced ﬂexibility is also observed for the carboxy-
terminal strand D (Figures 7(b) and 8(a)), which is involved
in both intramolecular interactions with strand C and in
gp120-binding. In contrast to the ﬂanking loops analyzed
above, strand D does not only exhibit enhanced local ﬂuc-
tuations but instead becomes completely detached from the
mCD4-M core and the gp120 interface. As a consequence,
the intermolecular K61-D368 salt-bridge, which is consid-
ered an important element of the gp120-CD4 complex, is
lost after 6ns. Consequently, the intrinsic peptide stability
is reduced and the gp120-peptide interface weakened. How-
ever, transient contacts detected between residues K60/K61
and several alternative gp120 residues may at least partially
compensate for the lost K61-D368 salt-bridge (Figure 7).
Although mCD4-M displays a rigid core aligning opti-
mally at the gp120-interface, simulation revealed strand D
to detach (Figures 7(b) and 8(a)), thereby destabilizing the
interaction. Therefore, we proposed that ﬁxation of strand D
to the peptide core might not only enhance intrinsic peptide
stability but also contribute to the preservation of interface
key contacts such as the K61-D368 salt-bridge. Structural
analysis suggested a disulﬁde bridge that ﬁxes the ﬂexible
C-terminus of mCD4-M to the peptide core. Due to their
spatial proximity in the initial model, a peptide containing
a disulﬁde bridge between cysteine residues at positions 23
and65wasexpectedtoenhancepeptidestability(Table 2 and
Figure 8(b)).
Subsequent binding assays involving this cyclic peptide
(mCD4-M∗∗) conﬁrmed that it binds gp120 with a signif-
icantly higher aﬃnity than linear mCD4-M (Figure 3), val-
idating the proposed beneﬁcial eﬀect of the conformational
constraint introduced by the disulﬁde bond.
In conclusion, the presented study provides an excellent
example of how a combination of computational and exper-
imental methods can be used to shed light on the structural
basis of species selectivity in protein-protein interactions, as
well as to design and generate molecules with desired qual-
ities. Furthermore, this strategy is of signiﬁcant potential
beneﬁt for the process of structure-based design of synthet-
ic protein mimics, by proposing ways to avoid spatial hin-
drance, thus improving structural complementarity, and,
consequently, aﬃnity between the molecules involved. CD4-
derived peptides, which speciﬁcally and with high aﬃnity
target the CD4-binding site of gp120, are potential candi-
dates for the development of HIV-1 entry inhibitors. The
cyclic murine CD4 mimetic peptide proposed here may,
therefore, serve as a starting point for the development of
such a drug molecule.
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